These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29433446)

  • 1. Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study.
    Chen CJ; Yang TC; Chang C; Lu SC; Chang PY
    BMC Cardiovasc Disord; 2018 Feb; 18(1):33. PubMed ID: 29433446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Li J; Zhou Y; Zhang Y; Zheng J
    BMC Cardiovasc Disord; 2018 Jun; 18(1):125. PubMed ID: 29940881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors for In-Hospital and Long-Term Survival in Patients with Acute ST-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.
    Hou LL; Gao C; Feng J; Chen ZF; Zhang J; Jiang YJ; Li XX; Wang BN
    Tohoku J Exp Med; 2017 May; 242(1):27-35. PubMed ID: 28496014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of serum uric acid and Killip class on mortality after acute ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.
    Liu CW; Liao PC; Chen KC; Chiu YW; Liu YH; Ke SR; Wu YW
    Int J Cardiol; 2017 Jan; 226():26-33. PubMed ID: 27780079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
    Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
    Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction.
    Sheng Z; Tan Y; Liu C; Zhou P; Li J; Zhou J; Chen R; Chen Y; Song L; Zhao H; Yan H
    Am J Cardiol; 2019 Mar; 123(6):894-898. PubMed ID: 30594289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function.
    Fan L; Liu B; Guo R; Luo J; Li H; Li Z; Xu W
    Int J Med Sci; 2019; 16(8):1171-1179. PubMed ID: 31523180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between serum homocysteine levels and long-term outcomes in patients with ST-segment elevation myocardial infarction.
    Si J; Li XW; Wang Y; Zhang YH; Wu QQ; Zhang LM; Zuo XB; Gao J; Li J
    Chin Med J (Engl); 2019 May; 132(9):1028-1036. PubMed ID: 30829711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
    Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
    Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of plasma 25-(OH) vitamin D levels in acute ST elevation myocardial infarction.
    Şen Ö; Topuz M; Acele A; Akkuş O; Baykan AO; Koç M
    Cardiol J; 2017; 24(6):677-684. PubMed ID: 28612906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction.
    Liu K; Tang Q; Zhu X; Yang X
    Clin Chim Acta; 2017 May; 468():140-144. PubMed ID: 28237549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
    Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
    Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Sulfatide, A Novel Biomarker for ST-Segment Elevation Myocardial Infarction.
    Li G; Hu R; Guo Y; He L; Zuo Q; Wang Y
    J Atheroscler Thromb; 2019 Jan; 26(1):84-92. PubMed ID: 29887538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive atorvastatin improves endothelial function and decreases ADP-induced platelet aggregation in patients with STEMI undergoing primary PCI: A single-center randomized controlled trial.
    Xu X; Liu Y; Li K; Wang P; Xu L; Yang Z; Yang X
    Int J Cardiol; 2016 Nov; 222():467-472. PubMed ID: 27505335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI.
    Saia F; Komukai K; Capodanno D; Sirbu V; Musumeci G; Boccuzzi G; Tarantini G; Fineschi M; Tumminello G; Bernelli C; Niccoli G; Coccato M; Bordoni B; Bezerra H; Biondi-Zoccai G; Virmani R; Guagliumi G;
    JACC Cardiovasc Imaging; 2015 May; 8(5):566-575. PubMed ID: 25890582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 serum level has prognostic value in patients with ST-segment elevation myocardial infarction.
    Zykov MV; Barbarash OL; Kashtalap VV; Kutikhin AG; Barbarash LS
    Heart Lung; 2016; 45(4):336-40. PubMed ID: 27094852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
    Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
    Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.